What does Dr. Tjorven Audenaert, cardiologie do?

Dr. Tjorven Audenaert, cardiologie is a specialist medical practice in Aalter. Private Limited, started on 30 December 2019, 1 establishment.

What is the address of Dr. Tjorven Audenaert, cardiologie?

The registered office of Dr. Tjorven Audenaert, cardiologie is located at De Conincksgoed 59, 9881 Aalter.

Is Dr. Tjorven Audenaert, cardiologie still active?

Yes. According to the CBE (27 September 2026) Dr. Tjorven Audenaert, cardiologie is active, legal situation “Normale toestand”, started on 30 December 2019.

Is Dr. Tjorven Audenaert, cardiologie registered on Peppol?

Yes, Dr. Tjorven Audenaert, cardiologie is registered on the Peppol network with ID 0208:0740593911.

What is the enterprise number of Dr. Tjorven Audenaert, cardiologie?

The enterprise number of Dr. Tjorven Audenaert, cardiologie is BE0740593911.

When was Dr. Tjorven Audenaert, cardiologie founded?

Dr. Tjorven Audenaert, cardiologie was founded on 30 December 2019.

Who are the directors of Dr. Tjorven Audenaert, cardiologie?

According to the 2025 annual accounts, the directors of Dr. Tjorven Audenaert, cardiologie are: Tjorven Audenaert.

Is Dr. Tjorven Audenaert, cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Tjorven Audenaert, cardiologie make in 2025?

Dr. Tjorven Audenaert, cardiologie posted a profit after taxes of € 301,806 in financial year 2025.

What is the revenue of Dr. Tjorven Audenaert, cardiologie?

As a small company, Dr. Tjorven Audenaert, cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 397,718.

Dr. Tjorven Audenaert, cardiologie (Private Limited)

Dossier Dr. Tjorven Audenaert, cardiologie, printed on 27 September 2026 from databakkes.be/en/0740593911/dr-tjorven-audenaert-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

Dr. Tjorven Audenaert, cardiologie from Aalter, company number BE0740593911, closed financial year 2025 with a result of € 301,806 after tax. For that financial year Dr. Tjorven Audenaert, cardiologie recorded a gross margin of € 397,718 and equity of € 29,191. Compared with financial year 2024, the result moved from € 310,590 to € 301,806. The company is profitable. The buffer shrank hard: equity is 91 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Shrank hard

€ 29,191

▼ 91% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 301,806

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 238,985

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 601,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 214

▼ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,421

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,040

▲ 6% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 262,514 Gross margin 2022: € 262,514 First fiscal year in the series	€ 338,882 Gross margin 2023: € 338,882 ▲ 29% vs 2022 (€ 262,514) Favourable step	€ 406,029 Gross margin 2024: € 406,029 ▲ 20% vs 2023 (€ 338,882) Favourable step	€ 397,718 Gross margin 2025: € 397,718 ▼ 2% vs 2024 (€ 406,029) Unfavourable step	▼ 2%
Profit after taxes	€ 204,768 Profit after taxes 2022: € 204,768 First fiscal year in the series	€ 267,246 Profit after taxes 2023: € 267,246 ▲ 31% vs 2022 (€ 204,768) Favourable step	€ 310,590 Profit after taxes 2024: € 310,590 ▲ 16% vs 2023 (€ 267,246) Favourable step	€ 301,806 Profit after taxes 2025: € 301,806 ▼ 3% vs 2024 (€ 310,590) Unfavourable step	▼ 3%
Equity	€ 658,204 Equity 2022: € 658,204 First fiscal year in the series	€ 28,979 Equity 2023: € 28,979 ▼ 96% vs 2022 (€ 658,204) Unfavourable step	€ 328,385 Equity 2024: € 328,385 ▲ € 299,406 vs 2023 (€ 28,979) Favourable step	€ 29,191 Equity 2025: € 29,191 ▼ 91% vs 2024 (€ 328,385) Unfavourable step	▼ 91%
Total debts	€ 26,419 Total debts 2022: € 26,419 First fiscal year in the series	€ 263,829 Total debts 2023: € 263,829 ▲ € 237,411 vs 2022 (€ 26,419) Unfavourable step	€ 40,161 Total debts 2024: € 40,161 ▼ 85% vs 2023 (€ 263,829) Favourable step	€ 248,638 Total debts 2025: € 248,638 ▲ € 208,476 vs 2024 (€ 40,161) Unfavourable step	▲ € 208,476
Cash	€ 670,235 Cash 2022: € 670,235 First fiscal year in the series	€ 292,088 Cash 2023: € 292,088 ▼ 56% vs 2022 (€ 670,235) Unfavourable step	€ 368,080 Cash 2024: € 368,080 ▲ 26% vs 2023 (€ 292,088) Favourable step	€ 238,985 Cash 2025: € 238,985 ▼ 35% vs 2024 (€ 368,080) Unfavourable step	▼ 35%
Retained profit	€ 656,704 Retained profit 2022: € 656,704 First fiscal year in the series	€ 27,479 Retained profit 2023: € 27,479 ▼ 96% vs 2022 (€ 656,704) Unfavourable step	€ 326,885 Retained profit 2024: € 326,885 ▲ € 299,406 vs 2023 (€ 27,479) Favourable step	€ 27,691 Retained profit 2025: € 27,691 ▼ 92% vs 2024 (€ 326,885) Unfavourable step	▼ 92%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 896,471 Dividend 2023: € 896,471 ▲ € 894,871 vs 2022 (€ 1,600) Unchanged	€ 11,184 Dividend 2024: € 11,184 ▼ 99% vs 2023 (€ 896,471) Unchanged	€ 601,000 Dividend 2025: € 601,000 ▲ € 589,816 vs 2024 (€ 11,184) Unchanged	▲ € 589,816
Balance sheet total	€ 684,622 Balance sheet total 2022: € 684,622 First fiscal year in the series	€ 292,808 Balance sheet total 2023: € 292,808 ▼ 57% vs 2022 (€ 684,622) Unchanged	€ 368,547 Balance sheet total 2024: € 368,547 ▲ 26% vs 2023 (€ 292,808) Unchanged	€ 277,829 Balance sheet total 2025: € 277,829 ▼ 25% vs 2024 (€ 368,547) Unchanged	▼ 25%

Key figures of Dr. Tjorven Audenaert, cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Tjorven Audenaert, cardiologie?

What happened at Dr. Tjorven Audenaert, cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 301,806 (▼ 3% vs 2024). Source: NBB ↗
Dec 30, 2019 New establishment in Aalter. KBO
Dec 30, 2019 Start of the company according to the CBE. KBO

In short

From € 204,768 profit in 2022 to € 301,806 profit in 2025.

Paid € 317,248 in corporate taxes since 2022.

Best year ever: 2024, with € 310,590 profit.

Paid out € 1.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Tjorven Audenaert, cardiologie? We notify you, reason included.

Follow Dr. Tjorven Audenaert, cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Tjorven Audenaert

Dr. Tjorven Audenaert, cardiologie

Behind Dr. Tjorven Audenaert, cardiologie is Tjorven Audenaert.

See the full network in the app

Directors

According to the 2025 annual accounts

Tjorven Audenaert

Director

Establishments

Establishment units

Physical locations of this company

Registered office

De Conincksgoed 59

9881 Aalter

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0740.593.911
VAT number: BE 0740.593.911
Registered office: De Conincksgoed 59, 9881 Aalter
Names & denominations: Dr. Tjorven Audenaert, cardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 December 2019
Peppol: Active · Active since 31 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗